Combo treatment improved overall survival rates in follicular non-Hodgkin lymphoma Radioimmunotherapy after chemotherapy is safe and effective for patients with follicular non-Hodgkin lymphoma (NHL), ...

A patient's initial response to warfarin is determined largely by their vitamin K epoxide reductase (VKORC1) genotype, study findings published in the New England Journal of Medicine show. ...

Multimerin 1 is a massive, soluble, disulfide-linked homopolymeric protein that is expressed in megakaryocytes, platelets and endothelial cells. Normally, multimerin 1 undergoes efficient sorting ...

Abstract: We have performed a detailed investigation of the effects on platelet function of coenzyme A (CoA) and several acyl-CoAs. Platelet aggregation was measured by turbidimetry and by platelet ...

Transplantation of healthy cells to repair organ damage or replace deficient functions constitutes a major goal of cell therapy. However, the mechanisms by which transplanted cells engraft, ...

Unlike the rest of the cells in your body, your red blood cells lack nuclei. That quirk dates back to the time when mammals began to evolve. Other vertebrates such as fish, reptiles, and birds, have ...

The pain that adults with sickle cell disease experience has been greatly underestimated, primarily because these patients usually manage their symptoms alone without seeking health care, study ...

Eltrombopag Effective for Hepatitis C Patients With Low Blood-Platelet Counts. NEW YORK (Dec. 28, 2007) For patients with hepatitis C, having a low blood platelet count is a frequent complication ...

Among patients undergoing cardiac catheterization with planned PCI, a 60-mg loading dose of prasugrel (Daiichi Sankyo, Eli Lilly) resulted in greater platelet inhibition than a 600-mg loading dose of ...

ZOLINZA (vorinostat) in combination with bortezomib demonstrated clinical activity in investigational studies of patients with advanced multiple myeloma ATLANTA, GA, December 8, 2007 -- Results from ...

ATLANTA -- Results of Eastern Cooperative Oncology Group Phase III clinical trial E4A03, for multiple myeloma, showing significantly better overall survival with lenalidomide plus low-dose ...

ATLANTA - Two drugs approved for use as second line therapy for chronic myelogenous leukemia are showing promising results as frontline therapy for newly diagnosed patients in two clinical trials, ...

COLUMBUS, Ohio – Scientists here have found that mini-molecules called micro-RNA may play a critical role in the progression of chronic myeloid leukemia (CML) from its more treatable chronic phase to ...

PORTLAND, Ore. – Gleevec, the targeted cancer pill that has saved more than 100,000 lives, now is saving more children with a dire leukemia, as well as preventing disease progression with long term ...

Abstract Delayed hypersensitivity (HS) reactions to sulphonamide antimicrobials occur in both humans and dogs with a similar clinical presentation, and may include thrombocytopaenia. Drug-dependent ...